Li-Cor supports virology research for COVID-19

By The Science Advisory Board staff writers

July 7, 2020 -- Li-Cor Biosciences offers research solutions for therapeutics development and western blotting. Now, the company is offering researchers a special Odyssey Clx Viral Solution package at a reduced price to support COVID-19 research.

Traditionally, researchers use plaque assays to determine infectivity of SARS-CoV-2 and other viruses. Alternatively, Li-Cor's near-infrared western blot and in-cell western assays offer a rapid and reliable method to study viruses like SARS-CoV-2.

The package includes the Odyssey Imager, startup reagents, basic and advanced virtual training from Li-Cor scientists, and Empiria Studio statistical analysis software.


Copyright © 2020 scienceboard.net
 


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.